N-myristoyl-D-erythro-sphingosine
面议
脂类

N-myristoyl-D-erythro-sphingosine

  • 全国
  • 阿拉丁
  • 上海
  • 生产商
  • 现货
  • 3
  • 0
上海阿拉丁生化科技股份有限公司
高级会员 高级会员
产品特点
规格信息
货号 CAS号
N130619-100mg 123408-74-2
N130619-25mg 123408-74-2
N130619-5mg 123408-74-2
更多参数>>
产品描述
  • 分子式 C32H63NO3
  • 分子量509.848
  • Beilstein号
  • EC号
  • MDL号
  • PubChem编号

属性

存贮条件 储存温度 -20°C

描述

应用 C14 Ceramide (d18:1/14:0) is suitable for use
· as a standard in high-performance liquid chromatography/tandem mass spectrometry (LC/MS2) for ceramide quantification from muscel biopsies
· in lipid monolayer preparation for biophysical studies
· in the morphological and dimensional evaluation studies
产品介绍 Ceramide synthesis is majorly driven by de novo pathway involving the palmitoyl-CoA and L-serine, and also by salvage pathway via recycling of complex sphingolipids. The ceramide transporter, Cert mediates the transfer of C14 from smooth endoplasmic reticulum to Golgi. Ceramide synthase CerS6 enzyme is involved in the synthesis of C14 ceramide
生化机理 Ceramides regulate biological processes including proliferation, differentiation and apoptosis.[6] In the cystic fibrosis patients, elevated levels of C14 ceramide is observed. It is also a potential biomarker for hepatic steatosis (HS) and C14 ceramide levels correlate with the aspartate aminotransferase (AST) / alanine transaminase (ALT) ratio. Tumor necrosis factor α (TNFα) mediates increase in the C14 levels. Fumonisin B1 prevents the C14 accumulation.
别名 N-(tetradecanoyl)-sphing-4-enine ;C14 Ceramide (d18:1/14:0); N-myristoyl-D-erythro-sphingosine; (2S,3R,4E)-2-(Myristoylamino)-4-octadecene-1,3-diol, N-Myristoyl-D-erythro-sphingosine, N-Tetradecanoyl-D-sphingosine, N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]tetradecanamide, C14-Ceramide, Cer(d18:1/14:0); N-Myristoyl-D-sphingosine
店铺 购物车
加入购物车
咨询 拨号
AI问答 配套的仪器设备? X